Antibodies mimic natural oxidosqualene-cyclase action in steroid ring a formation

Journal of the American Chemical Society

Volumn 122, Issue 1, 2000, Pages 40-45

  Hasserodt, Jens ^a   Janda, Kim D ^a   Lerner, Richard A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; LANOSTEROL; SQUALENE DERIVATIVE; STEROID; TRITERPENE;

ANTIGEN ANTIBODY REACTION; ARTICLE; BINDING AFFINITY; CHEMICAL REACTION; CYCLIZATION; ENANTIOMER; ENZYME SPECIFICITY; HYDROLYSIS; HYDROPHOBICITY; RACEMIC MIXTURE; SOLUBILIZATION; STEREOCHEMISTRY; THIN LAYER CHROMATOGRAPHY;

EID: 0034639446     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja993054l     Document Type: Article

References (45)

1. Sacchettini, J. C.; Poulter, C. D. Science 1997, 277, 1788-1789.
2. Geranyl-, farnesyl-, and geranylgeranyl pyrophosphate, squalene, and 2, 3-(S)-oxidosqualene.
3. (a) Abe, I.; Rohmer M.; Prestwich, G. D. Chem. Rev. 1993, 93, 2189-2206.
4. (b) Ourrisson, G.; Rohmer, M.; Poralla, K. Ann. Rev. Microbiol. 1987, 41, 301-333.
5. For current developments in nonenzymic poly-ene cyclizations, see: (a) Sen, S. E.; Zhang, Y. z.; Smith, S. M. J. Org. Chem. 1998, 63, 4459-4465. (b) Xing, X.; Demuth, M. Synlett 1999, S1, 987-989.
6. For current developments in nonenzymic poly-ene cyclizations, see: (a) Sen, S. E.; Zhang, Y. z.; Smith, S. M. J. Org. Chem. 1998, 63, 4459-4465. (b) Xing, X.; Demuth, M. Synlett 1999, S1, 987-989.
7. (a) Li T.; Janda K. D.; Ashley J. A.; Lerner R. A. Science 1994, 264, 1289-1293.
8. (b) Hasserodt, J.; Janda, K. D.; Lerner, R. A. J. Am. Chem. Soc. 1996, 118, 11654-11655.
9. (c) Li, T.; Janda, K. D.; Lerner, R. A. Nature 1996, 379, 326-327.
10. (d) Li, T.; Lerner, R. A.; Janda, K. D. Acc. Chem. Res. 1997, 30, 115-121.
11. (a) Hasserodt, J.; Janda, K. D.; Lerner, R. A. J. Am. Chem. Soc. 1997, 119, 5993-5998.
12. (b) Hasserodt, J.; Janda, K. D. Tetrahedron 1997, 53, 11237-11256.
13. Paschall, C.; Hasserodt, J.; Jones, T.; Lerner, R. A.; Janda, K. D.; Christianson, D. W. Angew. Chem., Int. Ed. Engl. 1999, 38, 1743-1747.
14. (a) Wendt, K. U.; Poralla, K.; Schulz, G. E. Science 1997 277, 1811-1815.
15. (b) Wendt, K. U.; Lenhardt, A.; Schulz, G. E. J. Mol. Biol. 1999 286, 175-187.
16. (c) Starks, C. M.; Back, K.; Chappell, J.; Noel, J. P. Science 1997, 277, 1815-1820.
17. (d) Lesburg, C. A.; Zhai, G.; Cane, D. E.; Christianson, D. W. Science 1997, 277, 1820-1824.
18. (a) Dougherty, D. Science 1996, 275, 1800-1804.
19. (b) Lesburg, C. A.; Caruthers, J. M.; Paschall, C. M.; Christianson, D. W. Curr. Op. Struct. Biol. 1998, 8, 695-703.
20. Jenson, C.; Jorgensen, W. L. J. Am. Chem. Soc. 1997, 119, 10846-10854.
21. Cerutti, M.; Delprino, L.; Cattel, L.; Bouvier-Nave, P.; Duriatti, A.; Schuber, F.; Benveniste, P. J. Chem. Soc., Chem. Commun. 1985, 1054-1055.
22. Janda, K. D.; Shevlin, C. G.; Lerner, R. A. Science 1993, 259, 490-493.
23. Hasserodt, J.; Janda, K. D.; Lerner, R. A. Bioorg. Med. Chem. In press.
24. Please note the reversal of substrate orientation when comparing this strategy (and the strategy by SHC) with an earlier concept. See ref 3b.
25. Mader, M. M.; Bartlett, P. A. Chem. Rev. 1997, 97, 1281-1301.
26. (a) van Tamelen, E. E.; Curphey, T. J. Tetrahedron Lett. 1962, 121-124.
27. (b) Xiao, Y.; Prestwich, G. D. J. Labelled Compd. Radiopharm. 1991, 29, 883-890.
28. (c) Ceruti, M.; Rocco, F.; Viola, F.; Balliano, G.; Milla, P.; Arpicco, S.; Cattel, L. J. Med. Chem. 1998, 41, 540-554.
29. See Supporting Information for synthesis scheme and NMR characterization.
30. Goldsmith, D. J. J. Am. Chem. Soc. 1962, 84, 3913-3918.
31. Corey, E. J.; Cheng, H.; Baker, C. H.; Matsuda, S. P. T.; Li, D.; Song, X. J. Am. Chem. Soc. 1997, 119, 1277-1288.
32. 6
33. 6,23,28
34. The presence of a third, minor isomer with a double bond between C3 and C4 was not observed.
35. Barrero, A. F.; Manzaneda, E. A.; Manzaneda, R. A. Tetrahedron 1990, 46, 8161-8168.
36. (a) Dale, J. A.; Mosher, H. S. J. Am. Chem. Soc. 1973, 95, 512-519.
37. (b) Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092-4096.
38. See Supporting Information.
39. Moore, W. R.; Schatzmann, G. L. J. Biol. Chem. 1992, 267, 22003-22006.
40. (a) Feil, C.; Poralla, K. Eur. J. Biochem. 1996, 242, 51-55.
41. (b) Sato, T.; Kanai, Y.; Hoshino, T. Biosci. Biotechnol. Biochem. 1998, 62, 407-411.
42. Hoshino, T.; Ishibashi, E.; Kaneko, K. J. Chem. Soc., Chem. Commun. 1995, 2401-2402.
43. This hypothesis will now be tested by synthesizing substrates displaying various methylation patterns to further probe antibody HA8-25A10.
44. Pauling, L. Chem. Eng. News 1946, 24, 1375-1377.
45. Bernassau, J. M.; Fetizon, M. Synthesis 1975, 795-796 and references therein.